Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate ...
FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...
Journey Medical launches Emrosi for the treatment of rosacea
Journey Medical (DERM) announced the launch of and the first prescriptions filled for Emrosi(TM) (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended ...
MPR1 天
Emrosi Now Available for the Treatment of Rosacea
Emrosi™ (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea ...